Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
19.4%
% of XLV's 62 holdings also in PJP
48.0%
% of PJP's 25 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in PJP |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 7.1% | 5.5% | 5.5% | |
ABBVIE INC | 5.6% | 4.9% | 4.9% | |
MERCK & CO. INC. | 4.7% | 4.8% | 4.7% | |
ELI LILLY & CO | 11.3% | 4.5% | 4.5% | |
ABBOTT LABORATORIES | 3.9% | 6.0% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PJP
UNITEDHEALTH GROUP INC | 10.5% | |
ELI LILLY & CO | 6.8% | |
THERMO FISHER SCIENTIFIC INC | 3.8% | |
INTUITIVE SURGICAL INC | 3.6% | |
DANAHER CORP | 2.8% | |
STRYKER CORP | 2.6% | |
BOSTON SCIENTIFIC CORP | 2.5% | |
VERTEX PHARMACEUTICALS INC | 2.3% | |
MEDTRONIC PLC | 2.2% | |
ELEVANCE HEALTH INC | 1.8% |
XLV Underweight Relative to PJP
CORCEPT THERAPEUTICS INC | -5.1% | |
PACIRA PHARMACEUTICALS INC | -3.9% | |
PRESTIGE BRANDS HOLDINGS INC | -3.9% | |
JAZZ PHARMACEUTICALS PLC | -3.6% | |
LIGAND PHARMACEUTICALS-CL B | -3.6% | |
UNITED THERAPEUTICS CORP | -3.6% | |
SUPERNUS PHARMACEUTICALS INC | -3.5% | |
VIATRIS, INC. | -3.5% | |
AMNEAL PHARMACEUTICALS, INC. CLASS A | -3.4% | |
INNOVIVA, INC. | -3.4% |